Masimo receives FDA clearance for fingertip pulse oximeter measurement

Masimo recently announced that it has received FDA clearance for its respiration rate measurement from the pleth RRp on its MightySat Rx spot-check fingertip pulse oximeter. It was also indicated for use in the home.

Using the company’s RRp in MightSat Rx, respiration rate can be measured using the same optical sensor that measures SpO2, PR, Pi and PVi. The RRp is only given when the respiratory movement-induced signal is available in the pulsatile waveform and may not be available during conditions like irregular breathing or excessive movements.

The RRp on MightySat Rx offers a convenient, fast and portable option. It features the same measure-through motion and Low Perfusion SET pulse oximetry that is available in a number of Masimo bedside monitors.

MightySat Rx is small and lightweight and has an IP23 ingress rating. It provides about 1,800 spot checks and is available in black and white. The MightySat Rx also features a high-resolution color display that displays plethysmographic waveforms and has a Bluetooth wireless interface to the Masimo Professional Health mobile application that allowed for tracking, viewing trends and communicating measurements.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW